Baxter (BAX) reports Q4 EPS of $0.97, not providing guidance for full-year 2020

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. AAPL
10. SPY

Go back to Baxter (BAX) reports Q4 EPS of $0.97, not providing guidance for full-year 2020

Baxter Reports Fourth-Quarter and Full-Year 2019 Results, Completes Financial Restatement Process

March 17, 2020 7:25 AM EDT

Fourth-quarter sales of $3.0 billion increased 7% on a reported basis and 9% on an operational basis1 Fourth-quarter GAAP earnings per share (EPS) were a loss of $0.05; adjusted EPS1 totaled $0.97 Full-year sales of $11.4 billion increased 2% on a reported basis and 5% on an operational basis Full-year GAAP EPS were $1.93; adjusted EPS totaled $3.31 With submission of restated financials, company is now current in its SEC reporting obligations

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today announced its complete... More